X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SANOFI INDIA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SANOFI INDIA PFIZER/
SANOFI INDIA
 
P/E (TTM) x 29.1 33.0 88.1% View Chart
P/BV x 4.6 6.3 73.5% View Chart
Dividend Yield % 0.7 1.4 48.8%  

Financials

 PFIZER   SANOFI INDIA
EQUITY SHARE DATA
    PFIZER
Mar-16
SANOFI INDIA
Dec-16
PFIZER/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs2,7244,560 59.7%   
Low Rs1,6114,400 36.6%   
Sales per share (Unadj.) Rs440.91,028.5 42.9%  
Earnings per share (Unadj.) Rs48.7129.0 37.8%  
Cash flow per share (Unadj.) Rs75.8186.0 40.7%  
Dividends per share (Unadj.) Rs15.0068.00 22.1%  
Dividend yield (eoy) %0.71.5 45.6%  
Book value per share (Unadj.) Rs462.9753.6 61.4%  
Shares outstanding (eoy) m45.7523.03 198.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.94.4 112.9%   
Avg P/E ratio x44.534.7 128.1%  
P/CF ratio (eoy) x28.624.1 118.8%  
Price / Book Value ratio x4.75.9 78.8%  
Dividend payout %30.852.7 58.4%   
Avg Mkt Cap Rs m99,163103,174 96.1%   
No. of employees `0002.93.6 79.7%   
Total wages/salary Rs m2,7583,592 76.8%   
Avg. sales/employee Rs Th6,981.76,537.7 106.8%   
Avg. wages/employee Rs Th954.5991.4 96.3%   
Avg. net profit/employee Rs Th771.1819.8 94.1%   
INCOME DATA
Net Sales Rs m20,17023,686 85.2%  
Other income Rs m857708 121.1%   
Total revenues Rs m21,02824,394 86.2%   
Gross profit Rs m4,3105,281 81.6%  
Depreciation Rs m1,2391,313 94.3%   
Interest Rs m515 34.7%   
Profit before tax Rs m3,9234,661 84.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7941,691 106.1%   
Profit after tax Rs m2,2282,970 75.0%  
Gross profit margin %21.422.3 95.8%  
Effective tax rate %45.736.3 126.1%   
Net profit margin %11.012.5 88.1%  
BALANCE SHEET DATA
Current assets Rs m16,29915,673 104.0%   
Current liabilities Rs m7,5946,678 113.7%   
Net working cap to sales %43.238.0 113.6%  
Current ratio x2.12.3 91.5%  
Inventory Days Days6576 85.9%  
Debtors Days Days2622 115.4%  
Net fixed assets Rs m8,6228,098 106.5%   
Share capital Rs m458230 198.7%   
"Free" reserves Rs m20,72217,088 121.3%   
Net worth Rs m21,18017,356 122.0%   
Long term debt Rs m250-   
Total assets Rs m29,13725,400 114.7%  
Interest coverage x755.5311.7 242.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.9 74.2%   
Return on assets %7.711.8 65.2%  
Return on equity %10.517.1 61.5%  
Return on capital %19.026.9 70.5%  
Exports to sales %0.124.5 0.2%   
Imports to sales %17.528.0 62.5%   
Exports (fob) Rs m125,801 0.2%   
Imports (cif) Rs m3,5266,627 53.2%   
Fx inflow Rs m527,145 0.7%   
Fx outflow Rs m1406,846 2.0%   
Net fx Rs m-88299 -29.5%   
CASH FLOW
From Operations Rs m3,4363,226 106.5%  
From Investments Rs m-6,991-1,555 449.6%  
From Financial Activity Rs m-619-1,818 34.0%  
Net Cashflow Rs m-4,174-147 2,839.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 60.4 105.8%  
Indian inst/Mut Fund % 7.5 14.4 52.1%  
FIIs % 4.9 14.6 33.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 10.5 225.7%  
Shareholders   85,207 15,184 561.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 22, 2018 03:33 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS